 |
|
|||||
|
United Pharmacies Member |
||||||
|
||||||
|
Qvar - Beclomethasone
Product: QvarGeneric Name: Beclomethasone Packaging: Inhaler containing 200 doses of 50ug mcg strength, Inhaler containing 200 doses of 100ug mcg strength Manufactured by: 3M
QVAR™ Abbreviated Prescribing Information Presentation: Qvar 50 and Qvar 100 aerosols: Qvar 50 and Qvar 100 Autohalers: Each actuation of Qvar aerosol/Autohaler delivers beclomethasone dipropionate Ph Eur 50 mcg or 100 mcg ex-valve into the mouthpiece of the actuator. The beclomethasone dipropionate is in solution giving an extrafine aerosol. Indications: Prophylactic management of mild, moderate or severe asthma. Dosage: The recommended daily dose for Qvar is the same as fluticasone on a mcg for mcg basis and lower than current CFC beclomethasone dipropionate (CFC-BDP) and budesonide. The dose should be adjusted to individual patient needs. Adults and elderly: New patients: Mild asthma: 100 to 200 mcg daily in divided doses. Moderate asthma: 200 to 400 mcg daily in divided doses. Severe asthma: 400 to 800 mcg daily in divided doses. Transferring patients from CFC inhalers and budesonide DPI: Patients with well-controlled asthma: Step 1 - Decide the appropriate CFC-BDP or budesonide DPI dose after considering the patient’s current condition. Step 2 - Prescribe Qvar at about half this dose. Patients with poorly controlled asthma: switch from CFC-BDP or budesonide to Qvar at the same mcg for mcg dose. The maximum recommended dose is 800 mcg per day. Children: No definitive dosage data are available for children under 12 years. Contra-indications: Hypersensitivity to beclomethasone dipropionate or any other ingredient in Qvar. Special warnings and precautions: Qvar is not indicated for the immediate relief of asthma attacks or status asthmaticus. Patients should be advised to seek medical attention for review of their therapy if their asthma seems to be worsening. Patients receiving systemic steroids at high doses and/or for long periods should have stable asthma before transfer to inhaled steroids. Withdrawal of systemic steroids should be gradual. Patients should carry a steroid warning card and have adrenocortical function monitored. During periods of stress oral steroids may be necessary. Caution in patients with pulmonary tuberculosis. Interactions: None known. Side-effects: Rare: oral candidiasis, nausea and hoarseness. Paradoxical bronchospasm may occur. Systemic effects may occur with inhaled steroids, especially at high doses for prolonged periods. These include: adrenal suppression, growth retardation in children and adolescents, decrease in bone mineral density, cataract and glaucoma. Hypersensitivity reactions. Pregnancy and lactation: Caution in pregnancy and breast-feeding. Weigh benefits of treatment against potential hazards to mother and baby. Pharmaceutical precautions: Store below 30°C. Pressurised canister, do not puncture or burn. |
|
|||||||||||||||||||||||||||||||||||||||||||
| Copyright 2001-2010 Life Pharmacy and United Pharmacies. | |||||||||||||||||||||||||||||||||||||||||||||
